Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Alzheimer's Disease
66%
Mild Cognitive Impairment
16%
Autosomal Dominant Alzheimer's Disease
16%
Amnestic Mild Cognitive Impairment (aMCI)
12%
18F-THK5351
12%
Cortical Thickness
11%
Cortical Thinning
11%
Frontotemporal Dementia
11%
Positron Emission Tomography
9%
Amyloid Deposition
9%
Amyloid beta
9%
Cerebrospinal Fluid
9%
Symptom Onset
8%
Korean Patients
8%
Alzheimer's Disease Pathology
8%
Sporadic Alzheimer's Disease
8%
Amyloid Status
7%
Alzheimer's Disease Classification
7%
Dementia
7%
Alzheimer's Disease Patient
7%
Imaging Biomarkers
6%
Amyloid PET
6%
Standardized Uptake Value
6%
Dementia Diseases
6%
Vascular Cognitive Impairment
6%
Induced Pluripotent Stem Cells (iPSCs)
6%
Neurodegeneration
6%
Amyloid Accumulation
5%
Alzheimer's Disease Diagnosis
5%
Early Alzheimer's Disease
5%
Tau Pathology
5%
Mutation Carriers
5%
Disease Progression
5%
Brain Regions
5%
Cognitive Decline
5%
Disease Pathophysiology
5%
Neuroscience
Alzheimer's Disease
100%
Amyloid Protein
47%
Mild Cognitive Impairment
30%
Positron Emission Tomography
16%
Fluorine-18
15%
Positron Emission Tomography
15%
Cognitive Disorders
13%
Beta Amyloid
8%
Magnetic Resonance Imaging
8%
Magnetic Resonance Imaging
7%
Neurodegeneration
7%
Gray Matter
6%
Frontotemporal Dementia
6%
Stem Cell
6%
Down Syndrome
6%
Medicine and Dentistry
Alzheimer's Disease
48%
Amyloid Protein
24%
Autosomal Dominant Inheritance
17%
Tau
17%
Mild Cognitive Impairment
13%
Fluorine-18
11%
Biological Marker
10%
Positron Emission Tomography
10%
Polyethylene Terephthalate
10%
Cerebrospinal Fluid
9%
Magnetic Resonance Imaging
7%
Standardized Uptake Value
5%